By Benjamin Horney ( February 27, 2019, 2:31 PM EST) -- The life sciences business of The Blackstone Group LP on Wednesday announced the formation of Anthos Therapeutics Inc., a biotech focused on developing therapies for high-risk cardiovascular patients, with an initial capital investment of $250 million....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.